{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Brain", "Cholesterol", "Cytochrome P450", "In Silico", "Lipids", "Phytochemicals"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36404953", "DateRevised": {"Year": "2022", "Month": "11", "Day": "30"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "11", "Day": "16"}], "Language": ["eng"], "ELocationID": ["10.1007/s42485-022-00098-x"], "Journal": {"ISSN": "2524-4663", "JournalIssue": {"Volume": "13", "Issue": "4", "PubDate": {"Year": "2022"}}, "Title": "Journal of proteins and proteomics", "ISOAbbreviation": "J Proteins Proteom"}, "ArticleTitle": "Identification of potential inhibitors of brain-specific CYP46A1 from phytoconstituents in Indian traditional medicinal plants.", "Pagination": {"StartPage": "227", "EndPage": "245", "MedlinePgn": "227-245"}, "Abstract": {"AbstractText": ["Cytochrome P450 46A1 (CYP46A1) is a crucial enzyme in brain that converts cholesterol to 24 (S) hydroxy cholesterol thereby increasing its polarity to facilitate removal of excess cholesterol from the CNS. The inhibition of CYP46A1 with several synthetic molecules has been investigated extensively for treatment of Alzheimer's disease, Huntington's disease, glaucoma, and in hippocampal neurons from aged mice. However, phytochemicals have received far little attention in studies involving development of potential CYP46A1 inhibitors. Thus, in the present study phytoconstituents from Indian traditional medicinal plants; <i>Bacopa monnieri</i>, <i>Piper longum,</i> and <i>Withania somnifera,</i> were virtually screened for interaction with CYP46A1 using computational tools. Out of three plants, six molecules from <i>P. longum</i> and three molecules from <i>W. somnifera</i> were shortlisted to study interactions with CYP46A1 based on the physio-chemical parameters. Fargesin, piperolactam A and coumaperine from <i>P. longum</i> showed the higher binding affinity and the values were -\u00a010.3, -\u00a09.5, -\u00a09.0\u00a0kcal/moles respectively, whereas, withaferin A from <i>W. somnifera</i> had a binding affinity of -\u00a012.9\u00a0kcal/mol. These were selected as potential modulators as they exhibited suitable interactions with active site residues; Tyr109, Leu112, Trp368, Gly369, and Ala474. The selected molecules were further subjected to molecular dynamics simulation. Further, the pharmacological properties of molecules were also predicted using ADMET calculator and the data revealed that all the selected compounds had good absorption as well as solubility characteristics. In addition, sesamin, fargesin, piperolactam A, and coumaperine had minimal or no toxic effects. Thus, the study successfully identified compounds from Indian medicinal plants that may serve as potential inhibitors of CYP46A1 or base structures to design novel\u00a0CYP46A1 inhibitors, which may be effective in treating neurological conditions involving perturbed cholesterol homeostasis.", "The online version contains supplementary material available at 10.1007/s42485-022-00098-x."], "CopyrightInformation": "\u00a9 The Author(s), under exclusive licence to Springer Nature Singapore Pte Ltd. 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": ["grid.261674.0", "0000 0001 2174 5640"], "Affiliation": "Department of Biochemistry, Basic Medical Sciences Block-II, Sector-25, Panjab University, Chandigarh, 160014 India."}], "LastName": "Kaur", "ForeName": "Kuldeep", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["grid.467228.d", "0000 0004 1806 4045"], "Affiliation": "Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology (BHU), Varanasi, 221005 UP India."}], "LastName": "Devi", "ForeName": "Bharti", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["grid.261674.0", "0000 0001 2174 5640"], "Affiliation": "Department of Biochemistry, Basic Medical Sciences Block-II, Sector-25, Panjab University, Chandigarh, 160014 India."}, {"Identifier": ["grid.444644.2", "0000 0004 1805 0217"], "Affiliation": "Amity School of Biological Sciences, Amity University, Sector-82, Mohali, Punjab 140306 India."}], "LastName": "Agrawal", "ForeName": "Vishal", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["grid.467228.d", "0000 0004 1806 4045"], "Affiliation": "Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology (BHU), Varanasi, 221005 UP India."}], "LastName": "Kumar", "ForeName": "Rajnish", "Initials": "R"}, {"Identifier": ["0000-0001-6242-5811"], "AffiliationInfo": [{"Identifier": ["grid.261674.0", "0000 0001 2174 5640"], "Affiliation": "Department of Biochemistry, Basic Medical Sciences Block-II, Sector-25, Panjab University, Chandigarh, 160014 India."}], "LastName": "Sandhir", "ForeName": "Rajat", "Initials": "R"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "India", "MedlineTA": "J Proteins Proteom", "NlmUniqueID": "101697319", "ISSNLinking": "0975-8151"}, "CoiStatement": "Conflict of interestAuthors do not have any conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Alexandrov P, Cui JG, Zhao Y, Lukiw WJ. 24S-hydroxycholesterol induces inflammatory gene expression in primary human neural cells. NeuroReport. 2005;16:909\u2013913. doi: 10.1097/00001756-200506210-00007.", "ArticleIdList": ["10.1097/00001756-200506210-00007", "15931060"]}, {"Citation": "Anderson KW, Mast N, Hudgens JW, Lin JB, Turko IV, Pikuleva IA. Mapping of the allosteric site in cholesterol hydroxylase CYP46A1 for efavirenz, a drug that stimulates enzyme activity. J Biol Chem. 2016;291:11876\u201311886. doi: 10.1074/jbc.M116.723577.", "ArticleIdList": ["10.1074/jbc.M116.723577", "PMC4882454", "27056331"]}, {"Citation": "Azizidoost S, Babaahmadi-Rezaei H, Nazeri Z, Cheraghzadeh M, Kheirollah A. Amyloid beta increases ABCA1 and HMGCR protein expression, and cholesterol synthesis and accumulation in mice neurons and astrocytes. Biochim Biophys Acta Mol Cell Biol Lipids. 2022;1867(1):159069. doi: 10.1016/j.bbalip.2021.159069.", "ArticleIdList": ["10.1016/j.bbalip.2021.159069", "34744007"]}, {"Citation": "Berman HM, Battistuz T, Bhat TN, Bluhm WF, Bourne PE, Burkhardt K, et al. The protein data bank. Acta Crystallogr Sect D Biol Crystallogr. 2002;58:899\u2013907. doi: 10.1107/S0907444902003451.", "ArticleIdList": ["10.1107/S0907444902003451", "12037327"]}, {"Citation": "Bettio LEB, Rajendran L, Gil-Mohapel J. The effects of aging in the hippocampus and cognitive decline. Neurosci Biobehav Rev. 2017;79:66\u201386. doi: 10.1016/j.neubiorev.2017.04.030.", "ArticleIdList": ["10.1016/j.neubiorev.2017.04.030", "28476525"]}, {"Citation": "Bj\u00f6rkhem I, Meaney S. Brain Cholesterol: Long Secret Life behind a Barrier. Arterioscler Thromb Vasc Biol. 2004;24:806\u2013815. doi: 10.1161/01.ATV.0000120374.59826.1b.", "ArticleIdList": ["10.1161/01.ATV.0000120374.59826.1b", "14764421"]}, {"Citation": "Boussicault L, Alves S, Lamazi\u00e8re A, Planques A, Heck N, Moumn\u00e9 L, et al. CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington\u2019s disease. Brain. 2016;139:953\u2013970. doi: 10.1093/brain/awv384.", "ArticleIdList": ["10.1093/brain/awv384", "PMC4766376", "26912634"]}, {"Citation": "Bowers KJ, Chow E, Xu H, Dror RO, Eastwood MP, Gregersen B A, et al. (2006) Scalable algorithms for molecular dynamics simulations on commodity clusters. Proceedings of the ACM/IEEE conference on super computing (SC06) pp 86"}, {"Citation": "Cheng F, Li W, Zhou Y, Shen J, Wu Z, Liu G, et al. AdmetSAR: A comprehensive source and free tool for assessment of chemical ADMET properties. J Chem Inf Model. 2012;52:3099\u20133105. doi: 10.1021/ci300367a.", "ArticleIdList": ["10.1021/ci300367a", "23092397"]}, {"Citation": "Chobanian AV, Burrows BA, Hollander W. Body cholesterol metabolism in man. II. Measurement of the body cholesterol miscible pool and turnover rate. J Clin Invest. 1962;41:1738\u20131744. doi: 10.1172/JCI104632.", "ArticleIdList": ["10.1172/JCI104632", "PMC291096", "13879097"]}, {"Citation": "Durg S, Dhadde SB, Vandal R, Shivakumar BS, Charan CS. Withania somnifera (Ashwagandha) in neurobehavioural disorders induced by brain oxidative stress in rodents: A systematic review and meta-analysis. J Pharm Pharmacol. 2015;67:879\u2013899. doi: 10.1111/jphp.12398.", "ArticleIdList": ["10.1111/jphp.12398", "25828061"]}, {"Citation": "Go J, Park TS, Han GH, Park HY, Ryu YK, Kim YH, et al. Piperlongumine decreases cognitive impairment and improves hippocampal function in aged mice. Int J Mol Med. 2018;42:1875\u20131884. doi: 10.3892/ijmm.2018.3782.", "ArticleIdList": ["10.3892/ijmm.2018.3782", "PMC6108885", "30066827"]}, {"Citation": "Hudry E, Van Dam D, Kulik W, De Deyn PP, Stet FS, Ahouansou O, et al. Adeno-associated virus gene therapy with cholesterol 24-hydroxylase reduces the amyloid pathology before or after the onset of amyloid plaques in mouse models of alzheimer\u2019s disease. Mol Ther. 2010;18:44\u201353. doi: 10.1038/mt.2009.175.", "ArticleIdList": ["10.1038/mt.2009.175", "PMC2839219", "19654569"]}, {"Citation": "Hughes TM, Rosano C, Evans RW, Kuller LH. Brain cholesterol metabolism, oxysterols, and dementia. J Alzheimer\u2019s Dis. 2013;33:891\u2013911. doi: 10.3233/JAD-2012-121585.", "ArticleIdList": ["10.3233/JAD-2012-121585", "PMC4354887", "23076077"]}, {"Citation": "Irwin JJ, Shoichet BK. Zinc- A free database of commercially available compounds for Virtual Screening. J Chem Inf Model. 2005;45:177\u2013182. doi: 10.1021/ci049714+.", "ArticleIdList": ["10.1021/ci049714+", "PMC1360656", "15667143"]}, {"Citation": "Kaushik P, Ali M, Salman M, Tabassum H, Parvez S. Harnessing the mitochondrial integrity for neuroprotection: Therapeutic role of piperine against experimental ischemic stroke. Neurochem Int. 2021;149:105138. doi: 10.1016/j.neuint.2021.105138.", "ArticleIdList": ["10.1016/j.neuint.2021.105138", "34284077"]}, {"Citation": "Kim S, Thiessen PA, Bolton EE, Chen J, Fu G, Gindulyte A, et al. PubChem substance and compound databases. Nucleic Acids Res. 2016;44:D1202\u2013D1213. doi: 10.1093/nar/gkv951.", "ArticleIdList": ["10.1093/nar/gkv951", "PMC4702940", "26400175"]}, {"Citation": "Kim JH, Kwon SS, Jeong HU, Lee HS. Inhibitory effects of dimethyllirioresinol, epimagnolin a, eudesmin, fargesin, and magnolin on cytochrome P450 enzyme activities in human liver microsomes. Int J Mol Sci. 2017 doi: 10.3390/ijms18050952.", "ArticleIdList": ["10.3390/ijms18050952", "PMC5454865", "28468305"]}, {"Citation": "Kothandan R, Rajan CASG, Arjun J, Raj RRM, Syed S. Virtual screening of phytochemical compounds as potential inhibitors against SARS-CoV-2 infection. Beni-Suef Univ J Basic Appl Sci. 2021 doi: 10.1186/s43088-021-00095-x.", "ArticleIdList": ["10.1186/s43088-021-00095-x", "PMC7841026", "33527080"]}, {"Citation": "Kumar G, Patnaik R. Exploring neuroprotective potential of Withania somnifera phytochemicals by inhibition of GluN2B-containing NMDA receptors: An in silico study. Med Hypotheses. 2016;92:35\u201343. doi: 10.1016/j.mehy.2016.04.034.", "ArticleIdList": ["10.1016/j.mehy.2016.04.034", "27241252"]}, {"Citation": "Kuo PH, Lin CI, Chen YH, Chiu WC, Lin SH. A high-cholesterol diet enriched with polyphenols from Oriental plums (Prunus salicina) improves cognitive function and lowers brain cholesterol levels and neurodegenerative-related protein expression in mice. Br J Nutr. 2015;113:1550\u20131557. doi: 10.1017/S0007114515000732.", "ArticleIdList": ["10.1017/S0007114515000732", "25866056"]}, {"Citation": "Lee YS, Cha BY, Choi SS, Harada Y, Choi BK, Yonezawa T, et al. Fargesin improves lipid and glucose metabolism in 3T3-L1 adipocytes and high-fat diet-induced obese mice. BioFactors. 2012;38:300\u2013308. doi: 10.1002/biof.1022.", "ArticleIdList": ["10.1002/biof.1022", "22674784"]}, {"Citation": "Li Y, Yang X, Ma C, Qiao J, Zhang C. Necroptosis contributes to the NMDA-induced excitotoxicity in rat\u2019s cultured cortical neurons. Neurosci Lett. 2008;447:120\u2013123. doi: 10.1016/j.neulet.2008.08.037.", "ArticleIdList": ["10.1016/j.neulet.2008.08.037", "18723075"]}, {"Citation": "Lipinski CA. Lead- and drug-like compounds: The rule-of-five revolution. Drug Discov Today Technol. 2004;1:337\u2013341. doi: 10.1016/j.ddtec.2004.11.007.", "ArticleIdList": ["10.1016/j.ddtec.2004.11.007", "24981612"]}, {"Citation": "Lu J, Wu DM, Zheng YL, Hu B, Zhang ZF, Shan Q, et al. Quercetin activates AMP-activated protein kinase by reducing PP2C expression protecting old mouse brain against high cholesterol-induced neurotoxicity. J Pathol. 2010;222:199\u2013212. doi: 10.1002/path.2754.", "ArticleIdList": ["10.1002/path.2754", "20690163"]}, {"Citation": "L\u00fctjohann D, Breuer O, Ahlborg G, Nennesmo I, Sid\u00e9n \u00c5, Diczfalusy U, et al. Cholesterol homeostasis in human brain: Evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc Natl Acad Sci U S A. 1996;93:9799\u20139804. doi: 10.1073/pnas.93.18.9799.", "ArticleIdList": ["10.1073/pnas.93.18.9799", "PMC38509", "8790411"]}, {"Citation": "Mahley RW. Central nervous system lipoproteins: ApoE and regulation of cholesterol metabolism. Arterioscler Thromb Vasc Biol. 2016;36:1305\u20131315. doi: 10.1161/ATVBAHA.116.307023.", "ArticleIdList": ["10.1161/ATVBAHA.116.307023", "PMC4942259", "27174096"]}, {"Citation": "Mandlik DS, Namdeo AG. Pharmacological evaluation of Ashwagandha highlighting its healthcare claims, safety, and toxicity aspects. J Diet Suppl. 2020 doi: 10.1080/19390211.2020.1741484.", "ArticleIdList": ["10.1080/19390211.2020.1741484", "32242751"]}, {"Citation": "Mart\u00edn MG, Pfrieger F, Dotti CG. Cholesterol in brain disease: sometimes determinant and frequently implicated. EMBO Rep. 2014;15(10):1036\u20131052. doi: 10.15252/embr.201439225.", "ArticleIdList": ["10.15252/embr.201439225", "PMC4253844", "25223281"]}, {"Citation": "Mast N, Norcross R, Andersson U, Shou M, Nakayama K, Bjorkhem I, et al. Broad substrate specificity of human Cytochrome P450 46A1 which initiates cholesterol degradation in the brain. Biochemistry. 2003;42:14284\u201314292. doi: 10.1021/bi035512f.", "ArticleIdList": ["10.1021/bi035512f", "14640697"]}, {"Citation": "Mast N, White MA, Bjorkhem I, Johnson EF, Stout CD, Pikuleva IA. Crystal structures of substrate-bound and substrate-free cytochrome P450 46A1, the principal cholesterol hydroxylase in the brain. Proc Natl Acad Sci U S A. 2008;105:9546\u20139551. doi: 10.1073/pnas.0803717105.", "ArticleIdList": ["10.1073/pnas.0803717105", "PMC2474539", "18621681"]}, {"Citation": "Mast N, Charvet C, Pikuleva IA, Stout CD. Structural basis of drug binding to CYP46A1, an enzyme that controls cholesterol turnover in the brain. J Biol Chem. 2010;285:31783\u201331795. doi: 10.1074/jbc.M110.143313.", "ArticleIdList": ["10.1074/jbc.M110.143313", "PMC2951250", "20667828"]}, {"Citation": "Mast N, Linger M, Clark M, Wiseman J, Stout CD, Pikuleva IA. In silico and intuitive predictions of CYP46A1 inhibition by marketed drugs with subsequent enzyme crystallization in complex with fluvoxamine. Mol Pharmacol. 2012;82:824\u2013834. doi: 10.1124/mol.112.080424.", "ArticleIdList": ["10.1124/mol.112.080424", "PMC3477228", "22859721"]}, {"Citation": "Mast N, Zheng W, Stout CD, Pikuleva IA. Antifungal azoles: Structural insights into undesired tight binding to cholesterol-metabolizing CYP46A1S. Mol Pharmacol. 2013;84:86\u201394. doi: 10.1124/mol.113.085902.", "ArticleIdList": ["10.1124/mol.113.085902", "PMC3684827", "23604141"]}, {"Citation": "Mast N, Zheng W, Stout CD, Pikuleva IA. Binding of a cyano-and fluoro-containing drug bicalutamide to cytochrome P45046A1 unusual features and spectral response. J Biol Chem. 2013;288:4613\u20134624. doi: 10.1074/jbc.M112.438754.", "ArticleIdList": ["10.1074/jbc.M112.438754", "PMC3576067", "23288837"]}, {"Citation": "Maxfield FR, van Meer G. (2010) Cholesterol, the central lipid of mammalian cells. Curr Opin Cell Biol. 2010;22(4):422\u2013429. doi: 10.1016/j.ceb.2010.05.004.", "ArticleIdList": ["10.1016/j.ceb.2010.05.004", "PMC2910236", "20627678"]}, {"Citation": "Modi SJ, Tiwari A, Ghule C, Pawar S, Saste G, Jagtap S, et al. Pharmacokinetic study of withanosides and withanolides from Withania somnifera using Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry (UHPLC-MS/MS) Molecules. 2022;27:1\u201324. doi: 10.3390/molecules27051476.", "ArticleIdList": ["10.3390/molecules27051476", "PMC8912008", "35268576"]}, {"Citation": "Na S, Duan X, Wang R, Fan Y, Xue K, Tian S, et al. Chronic neuroinflammation Induced by lipopolysaccharide injection into the third ventricle induces behavioral changes. J Mol Neurosci. 2021;71:1306\u20131319. doi: 10.1007/s12031-020-01758-7.", "ArticleIdList": ["10.1007/s12031-020-01758-7", "33405196"]}, {"Citation": "Nandakumar N, Muthuraman S, Gopinath P, Nithya P, Gopas J, Kumar RS. Synthesis of coumaperine derivatives: Their NF-\u03baB inhibitory effect, inhibition of cell migration and their cytotoxic activity. Eur J Med Chem. 2017;125:1076\u20131087. doi: 10.1016/j.ejmech.2016.10.047.", "ArticleIdList": ["10.1016/j.ejmech.2016.10.047", "27810594"]}, {"Citation": "Nishi T, Kondo S, Miyamoto M, Watanabe S, Hasegawa S, Kondo S, et al. Soticlestat, a novel cholesterol 24-hydroxylase inhibitor shows a therapeutic potential for neural hyperexcitation in mice. Sci Rep. 2020;10:1\u201310. doi: 10.1038/s41598-020-74036-6.", "ArticleIdList": ["10.1038/s41598-020-74036-6", "PMC7553946", "33051477"]}, {"Citation": "Nongmai C, Kanokmedhakul K, Promgool T, Paluka J, Suwanphakdee C, Kanokmedhakul S. Chemical constituents and antibacterial activity from the stems and leaves of Piper wallichii. J Asian Nat Prod Res. 2022;24:344\u2013352. doi: 10.1080/10286020.2021.1933959.", "ArticleIdList": ["10.1080/10286020.2021.1933959", "34085561"]}, {"Citation": "O\u2019Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR. Open Babel: An Open chemical toolbox. J Cheminform. 2011;3:33. doi: 10.1186/1758-2946-3-33.", "ArticleIdList": ["10.1186/1758-2946-3-33", "PMC3198950", "21982300"]}, {"Citation": "P\u00e9rez-Ca\u00f1am\u00e1s A, Sarroca S, Melero-Jerez C, Porquet D, Sansa J, Knafo S, et al. A diet enriched with plant sterols prevents the memory impairment induced by cholesterol loss in senescence-accelerated mice. Neurobiol Aging. 2016;48:1\u201312. doi: 10.1016/j.neurobiolaging.2016.08.009.", "ArticleIdList": ["10.1016/j.neurobiolaging.2016.08.009", "27622776"]}, {"Citation": "Petrov AM, Kasimov MR, Zefirov AL. Brain cholesterol metabolism and its defects: Linkage to neurodegenerative diseases and synaptic dysfunction. Acta Naturae. 2016;8:58\u201373. doi: 10.32607/20758251-2016-8-1-58-73.", "ArticleIdList": ["10.32607/20758251-2016-8-1-58-73", "PMC4837572", "27099785"]}, {"Citation": "Pikuleva IA, Cartier N. Cholesterol hydroxylating Cytochrome P450 46A1: From mechanisms of action to clinical applications. Front Aging Neurosci. 2021;13:1\u201317. doi: 10.3389/fnagi.2021.696778.", "ArticleIdList": ["10.3389/fnagi.2021.696778", "PMC8297829", "34305573"]}, {"Citation": "Popiolek M, Izumi Y, Hopper AT, Dai J, Miller S, Shu HJ, Zorumski CF, Mennerick S. Effects of CYP46A1 inhibition on long-term-depression in hippocampal slices ex vivo and 24S-hydroxycholesterol levels in mice in vivo. Front Mol Neurosci. 2021;13:568641. doi: 10.3389/fnmol.2020.568641.", "ArticleIdList": ["10.3389/fnmol.2020.568641", "PMC7658267", "33192294"]}, {"Citation": "Ramasamy S, Chin SP, Sukumaran SD, Buckle MJC, Kiew LV, Chung LYC. In silico and in vitro analysis of bacoside A aglycones and its derivatives as the constituents responsible for the cognitive effects of Bacopa monnieri. PLoS One. 2015;10:1\u201319. doi: 10.1371/journal.pone.0126565.", "ArticleIdList": ["10.1371/journal.pone.0126565", "PMC4428790", "25965066"]}, {"Citation": "Raush E, Totrov M, Marsden BD, Abagyan R. A new method for publishing three-dimensional content. PLoS One. 2009;4:2\u20136. doi: 10.1371/journal.pone.0007394.", "ArticleIdList": ["10.1371/journal.pone.0007394", "PMC2754609", "19841676"]}, {"Citation": "Rosenzweig ES, Barnes CA. Impact of aging on hippocampal function: Plasticity, network dynamics, and cognition. Prog Neurobiol. 2003;69(3):143\u2013179. doi: 10.1016/s0301-0082(02)00126-0.", "ArticleIdList": ["10.1016/s0301-0082(02)00126-0", "12758108"]}, {"Citation": "Sch\u00f6nknecht P, L\u00fctjohann D, Pantel J, Bardenheuer H, Hartmann T, von Bergmann K, et al. Cerebrospinal fluid 24S-hydroxycholesterol is increased in patients with Alzheimer\u2019s disease compared to healthy controls. Neurosci Lett. 2002;324:83\u201385. doi: 10.1016/S0304-3940(02)00164-7.", "ArticleIdList": ["10.1016/S0304-3940(02)00164-7", "11983301"]}, {"Citation": "Shafaati M, Mast N, Beck O, Nayef R, Heo GY, Bj\u00f6rkhem-Bergman L, L\u00fctjohann D, Bj\u00f6rkhem I, Pikuleva IA. The antifungal drug voriconazole is an efficient inhibitor of brain cholesterol 24S-hydroxylase in vitro and in vivo. J Lipid Res. 2010;51(2):318\u2013323. doi: 10.1194/jlr.M900174-JLR200.", "ArticleIdList": ["10.1194/jlr.M900174-JLR200", "PMC2803233", "19474457"]}, {"Citation": "Shi J, Jia J, Tian S, Zhang H, An K, Zhu W, et al. Increased plasma level of 24S-hydroxycholesterol and polymorphism of CYP46A1 SNP (rs754203) are associated with mild cognitive impairment in patients with Type 2 diabetes. Front Aging Neurosci. 2021;13:1\u201311. doi: 10.3389/fnagi.2021.619916.", "ArticleIdList": ["10.3389/fnagi.2021.619916", "PMC8155290", "34054500"]}, {"Citation": "Srinivasan K. Black pepper and its pungent principle-piperine: A review of diverse physiological effects. Crit Rev Food Sci Nutr. 2007;47:735\u2013748. doi: 10.1080/10408390601062054.", "ArticleIdList": ["10.1080/10408390601062054", "17987447"]}, {"Citation": "Tian G, Kong Q, Lai L, Ray-Chaudhury A, Lin CL. Increased expression of cholesterol 24S-hydroxylase results in disruption of glial glutamate transporter EAAT2 association with lipid rafts: a potential role in Alzheimer's disease. J Neurochem. 2010;113(4):978\u2013989. doi: 10.1111/j.1471-4159.2010.06661.x.", "ArticleIdList": ["10.1111/j.1471-4159.2010.06661.x", "PMC3010752", "20193040"]}, {"Citation": "Trott O, Olson AJ. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2009;31:455\u2013461. doi: 10.1002/jcc.21334.", "ArticleIdList": ["10.1002/jcc.21334", "PMC3041641", "19499576"]}, {"Citation": "Ulhas RS, Malaviya A. In-silico validation of novel therapeutic activities of withaferin a using molecular docking and dynamics studies. J Biomol Struct Dyn. 2022;24:1\u201312. doi: 10.1080/07391102.2022.2078410.", "ArticleIdList": ["10.1080/07391102.2022.2078410", "35608923"]}, {"Citation": "Uniyal A, Mahapatra MK, Tiwari V, Sandhir R, Kumar R. Targeting SARS-CoV-2 main protease: structure based virtual screening, in silico ADMET studies and molecular dynamics simulation for identification of potential inhibitors. J Biomol Struct Dyn. 2022;40:3609\u20133625. doi: 10.1080/07391102.2020.1848636.", "ArticleIdList": ["10.1080/07391102.2020.1848636", "PMC7754935", "33226303"]}, {"Citation": "Wadhwa R, Yadav NS, Katiyar SP, Yaguchi T, Lee C, Ahn H, et al. Molecular dynamics simulations and experimental studies reveal differential permeability of withaferin-A and withanone across the model cell membrane. Sci Rep. 2021;11:1\u201315. doi: 10.1038/s41598-021-81729-z.", "ArticleIdList": ["10.1038/s41598-021-81729-z", "PMC7840742", "33504873"]}, {"Citation": "Wang G, Gao JH, He LH, Yu XH, Zhao ZW, Zou J, Wen FJ, Zhou L, Wan XJ, Tang CK. Fargesin alleviates atherosclerosis by promoting reverse cholesterol transport and reducing inflammatory response. Biochim Biophys Acta Mol Cell Biol Lipids. 2020;1865(5):158633. doi: 10.1016/j.bbalip.2020.158633.", "ArticleIdList": ["10.1016/j.bbalip.2020.158633", "31988050"]}, {"Citation": "Wang S, Chen G, Merlo Pich E, Affinito J, Cwik M, Faessel HM. Pharmacokinetics, pharmacodynamics and safety assessment of multiple doses of soticlestat in healthy volunteers. Br J Clin Pharmacol. 2022 doi: 10.1111/bcp.15225.", "ArticleIdList": ["10.1111/bcp.15225", "PMC9305210", "35001412"]}, {"Citation": "Xia Y, Yan M, Wang P, Hamada K, Yan N, Hao H, et al. Withaferin A in the treatment of liver diseases: progress and pharmacokinetic insights. Drug Metab Dispos. 2021;50(5):685\u2013693. doi: 10.1124/dmd.121.000455.", "ArticleIdList": ["10.1124/dmd.121.000455", "PMC9132099", "34903587"]}, {"Citation": "Zhang J, Liu Q. Cholesterol metabolism and homeostasis in the brain. Protein Cell. 2015;6:254\u2013264. doi: 10.1007/s13238-014-0131-3.", "ArticleIdList": ["10.1007/s13238-014-0131-3", "PMC4383754", "25682154"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "5", "Day": "9"}, {"Year": "2022", "Month": "7", "Day": "27"}, {"Year": "2022", "Month": "9", "Day": "29"}, {"Year": "2022", "Month": "11", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "11", "Day": "22", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "11", "Day": "21", "Hour": "3", "Minute": "47"}, {"Year": "2022", "Month": "11", "Day": "16"}], "PublicationStatus": "ppublish", "ArticleIdList": ["36404953", "PMC9667835", "10.1007/s42485-022-00098-x", "98"]}}], "PubmedBookArticle": []}